
Mission
To deliver diagnostic excellence through innovation, education, and an unwavering commitment to quality, so every result a laboratory produces is one they can trust.
Now FDA Cleared! Immuno Concepts’ IgG Anti-nDNA Fluorescent Test System for use with the Image Navigator®. Learn More →

This educational program is intended to provide an overview of ANA testing methods, ANA pattern identification, and the clinical significance of ANA results. The material presented will be of practical use to laboratory technologists, pathologists, clinicians, and rheumatologists. The academic level of the material will be intermediate, however, those who are new to the field or unfamiliar with pattern interpretation will benefit from this course.

To deliver diagnostic excellence through innovation, education, and an unwavering commitment to quality, so every result a laboratory produces is one they can trust.

To be the most trusted partner in autoimmune diagnostics, recognized for our science, our standards, and our commitment to those we serve.
Our work has always had two sides: pioneering the technology that advances autoimmune diagnostics, and ensuring the people who use it are equipped to get the most from it.
Led the industry shift from rodent tissue to HEp-2 cells, fundamentally improving the accuracy and reliability of ANA detection.
A patented substrate genetically enhanced for superior SS-A/Ro sensitivity, raising the clinical standard for autoimmune testing.
Independent studies worldwide have consistently confirmed HEp-2000®'s clinical superiority across diverse laboratory settings.
Since our founding, we have offered workshops to clinicians and laboratory staff, alongside online training, pattern atlases, and pocket guides.
Our quality management system reflects the same commitment to precision that has defined our products since day one.
News
Keeping you informed on our latest innovations, partnerships, and industry developments.
Tomorrow’s diagnostic challenges deserve today’s boldest thinking. At Immuno Concepts, we are ready for both.